Cargando…

Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case report

BACKGROUND: The use of checkpoint inhibitors has become increasingly important in the treatment of different cancers, including advanced muscle-invasive urothelial cancer and even in basal cell carcinoma. We present the case of a patient with advanced basal cell carcinoma and metastatic muscle-invas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Küronya, Zsófia, Danyi, Tímea, Balatoni, Tímea, Liszkay, Gabriella, Tóth, Erika, Biró, Krisztina, Géczi, Lajos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623930/ https://www.ncbi.nlm.nih.gov/pubmed/36316780 http://dx.doi.org/10.1186/s13256-022-03634-x

Ejemplares similares

Sunitinib Rechallenge After Other Targeted Therapies in Metastatic Renal Cell Carcinoma Patients: A Single-Center, Retrospective Study
por: Nagyiványi, Krisztián, et al.
Publicado: (2019)

Therapeutic and Adverse Effect of Anti-PD1 Immunotherapy in Melanoma: A Retrospective, Single-Institute Study of 222 Patients
por: Eikenes, Grethe, et al.
Publicado: (2023)

Predictive Markers of First Line Pazopanib Treatment in Kidney Cancer
por: Küronya, Zsófia, et al.
Publicado: (2020)

HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab
por: Ladányi, Andrea, et al.
Publicado: (2022)

Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas
por: Kis, Erika Gabriella, et al.
Publicado: (2019)

The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients
por: Kispál, Mihály, et al.
Publicado: (2022)

Low socioeconomic position is a risk factor for delay to treatment and mortality of testicular cancer patients in Hungary, a prospective study
por: Küronya, Zsófia, et al.
Publicado: (2021)

Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma
por: Ladányi, Andrea, et al.
Publicado: (2020)

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer
por: Aydin, Ahmet Murat, et al.
Publicado: (2017)

Recurrence of Urothelial Bladder Carcinoma in the Colon Presenting as Hematochezia
por: El Douaihy, Youssef, et al.
Publicado: (2016)

Assessing the impact of organ-specific lesion dynamics on survival in patients with recurrent urothelial carcinoma treated with atezolizumab or chemotherapy
por: Kerioui, M., et al.
Publicado: (2021)

De Novo Myasthenia Gravis Induced by Atezolizumab in a Patient with Urothelial Carcinoma
por: Thakolwiboon, Smathorn, et al.
Publicado: (2019)

Anti-tumor antibody profile analysis to harness the potentials of B cells in melanomas and the natural humoral immune response
por: Kotlan, Beatrix, et al.
Publicado: (2013)

Recurrent papillary renal cell carcinoma with concomitant ipsilateral upper urinary tract urothelial carcinoma and metachronous urothelial carcinoma of the bladder
por: Banapour, Pooya, et al.
Publicado: (2018)

Challenging tumour immunological techniques that help to track cancer stem cells in malignant melanomas and other solid tumours
por: Kotlan, Beatrix, et al.
Publicado: (2018)

Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
por: Lonergan, Peter E., et al.
Publicado: (2020)

Mandibular Metastasis of a Recurrent Poorly Differentiated Urothelial Bladder Carcinoma
por: Aoun, Georges, et al.
Publicado: (2020)

Intravesical therapy for urothelial carcinoma of the bladder
por: Manoharan, M.
Publicado: (2011)

Role of angiogenesis in urothelial bladder carcinoma
por: Fus, Łukasz Piotr, et al.
Publicado: (2016)

Bladder melanosis with concurrent urothelial carcinoma
por: Yau, Susanna E., et al.
Publicado: (2017)

Cutaneous metastasis of bladder urothelial carcinoma
por: Hasan, Osamah, et al.
Publicado: (2019)

Giant Cell Urothelial Carcinoma of Bladder
por: Wijesinghe, Harshima Disvini, et al.
Publicado: (2021)

Molecular classification of urothelial bladder carcinoma
por: Schwarzova, Lucia, et al.
Publicado: (2023)

Telomere instability in papillary bladder urothelial carcinomas: Comparison with grading and risk of recurrence
por: Mucciardi, Giuseppe, et al.
Publicado: (2014)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Role of GATA3 in Early-Stage Urothelial Bladder Carcinoma Local Recurrence
por: Popov, Hristo, et al.
Publicado: (2023)

“Immune B Cells know it better”: tumorimmunological panel assay to define tumor-associated antigen binding antibodies in patients with metastatic melanomas
por: Kotlan, Beatrix, et al.
Publicado: (2015)

Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report
por: Rkman, Deni, et al.
Publicado: (2019)

Pericardial malignant infiltration as the cause of sudden death of a patient with metastatic urothelial carcinoma treated with atezolizumab
por: Palacka, Patrik, et al.
Publicado: (2022)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

GSTM1 null and GSTT1 null: predictors of cisplatin-caused acute ototoxicity measured by DPOAEs
por: Budai, Barna, et al.
Publicado: (2020)

Bilateral proliferating Brenner tumor of the ovary associated with recurrent urothelial carcinoma of the urinary bladder
por: Ziadi, Sonia, et al.
Publicado: (2010)

Urethral Recurrence of Urothelial Carcinoma of the Bladder Following Radical Cystectomy: An Unusual Imaging Pattern
por: Özdemir, Meltem, et al.
Publicado: (2020)

Establishing the prediction models for recurrence and progression of T1G3 bladder urothelial carcinoma
por: Chen, Song, et al.
Publicado: (2019)

Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes
por: Ravanini, Juliana Naves, et al.
Publicado: (2021)

A new method to quantify the effect of co-medication on the efficacy of abiraterone in metastatic castration-resistant prostate cancer patients
por: Fekete, Bertalan, et al.
Publicado: (2023)

Nested variant of urothelial carcinoma of the urinary bladder
por: Terada, Tadashi
Publicado: (2011)

CD10 expression in urothelial carcinoma of the bladder
por: Bahadir, Burak, et al.
Publicado: (2009)

Comprehensive molecular characterization of urothelial bladder carcinoma
Publicado: (2014)

Protein Profiling of Bladder Urothelial Cell Carcinoma
por: Hu, Jinghai, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5oe7264rgkejndhhhcfs6heutk